Bioprinted Tissue is a revolutionary advancement in the field of regenerative medicine, leveraging 3D printing technology to fabricate living biological tissues. This cutting-edge technique involves layer-by-layer deposition of bioinks, which are composed of living cells, biomaterials, and signaling molecules. Bioprinting allows for the precise arrangement of cells and biomaterials to mimic the intricate structures of native tissues. This technology holds immense potential for creating functional tissues and organs for transplantation, overcoming limitations associated with organ shortages and donor compatibility. Researchers use various cell sources, including stem cells and patient-specific cells, to bioprint tissues tailored to individual needs. The bioinks provide a supportive matrix for cell growth, differentiation, and tissue development. Applications of bioprinted tissues range from skin grafts and cartilage regeneration to the development of complex organs like the heart and liver. Bioprinting has the potential to revolutionize organ transplantation by offering personalized, on-demand solutions. Challenges in bioprinting include optimizing vascularization for nutrient supply and waste removal within the printed tissues. Ethical considerations and regulatory frameworks are crucial in ensuring the safety and efficacy of bioprinted tissues for clinical applications. As bioprinting technology advances, it holds promise for addressing critical medical needs, advancing regenerative medicine, and transforming the landscape of organ transplantation, ultimately improving patient outcomes and quality of life.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States